Search results
Scientists say 5p herb could soothe anxiety and help you sleep better
Gloucestershire Live via Yahoo News UK· 11 hours agoFor instance, a study involving 64 individuals with chronic stress showed that those who consumed...
In new Alzheimer’s criteria, some see progress while others fear profit-driven ‘diagnostic creep’
CNN via Yahoo News UK· 10 hours agoWith a second pricey drug to treat Alzheimer’s disease set to receive an approval decision soon, the...
Two reasons I’m sceptical about psychedelic science
The Conversation via Yahoo News UK· 9 hours agoThe main concern is called the “breaking blind problem”. In psychedelic studies, patients easily figure out if they have been randomly assigned to the...
One in ten NHS trusts offering 'quack' treatments to cancer patients
Daily Mail· 10 hours agoExcellence only recommending the treatments in specific circumstances. These include lessons on...
Nipocalimab pivotal Phase 3 trial demonstrates sustained disease control in FcRn class for a broad...
PharmiWeb· 20 hours agoPatients treated with nipocalimab plus standard of care (SOC) achieved superiority over placebo plus SOC as measured by the primary endpoint of improvement in the Myasthenia ...
SMALL CAP IDEA: Ananda punches above its weight with pain medicine
This Is Money· 12 hours ago'We punch well above our weight,' says Jeremy Sturgess-Smith, the co-founder and finance director of...
AstraZeneca's COVID-19 Prevention Drug For Patients With Weak Immune Systems - European Medicines...
Benzinga via Yahoo Finance UK· 8 hours agoThe European Medicines Agency (EMA) has accepted AstraZeneca Plc's (NASDAQ:AZN) marketing...
Biophytis Presented its Phase 2-3 COVA Study Results in Severe Forms of Covid-19 at the WCID in Pari...
PharmiWeb· 19 hours agoPARIS, FRANCE AND CAMBRIDGE, MA / ACCESSWIRE / July 1, 2024 / Biophytis SA (Euronext Growth Paris : ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized ...